Watch CBS News

Doctor explains promising melanoma vaccine

Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.
Aug 20 (05:01)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue